Δ4-THCΔ4-tetrahydrocannabinol (Δ6a,7-THC)
Synthetic THC isomer in Schedule I of the 1971 Convention, with no published pharmacology.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₁H₃₀O₂
CAS 59042-44-3
- Family
- Synthetic CB receptor agonistResearch ligand or medicine
- Molar mass
- 314.46 g/mol
Updated on
In plain terms
Δ4-THC is a laboratory-made variant of THC whose double bond sits elsewhere. It is classed as a controlled drug by the 1971 international convention, although its effects have not been studied.
Receptors and activity
Pharmacology
Δ4-THC, or Δ6a,7-THC in dibenzopyran numbering, is a positional isomer of tetrahydrocannabinol whose double bond lies between carbons 6a and 7. Arnone, Merlini and Servi described its synthesis in 1975, and, according to the 2018 WHO critical review, only the 9R,10aR isomer has been described, as a viscous oil. Schedule I of the 1971 Convention on Psychotropic Substances lists six isomers of Δ9-THC, this one among them, with their stereochemical variants; the WHO noted in 2018 that these isomers had never been subject to a critical review. The same report places Δ6a,7-THC among the isomers not assessed in any detail for toxicity and states that it may never have been tested for pharmacological activity; only Δ8-THC and Δ6a,10a-THC have been given to humans in pure form. No cannabinoid receptor affinity is published.
Key sources.
- WHO, Expert Committee on Drug Dependence. Isomers of THC: Critical Review Report, 41st meeting, 2018 (new tab)
- Arnone A, Merlini L, Servi S. Hashish: synthesis of (+)-Δ4-tetrahydrocannabinol. Tetrahedron 1975;31:3093-3096 (new tab)DOI 10.1016/0040-4020(75)80154-2
- ANSM, consolidated list of substances classified as narcotics, updated 16 February 2026 (annex III, « Tetrahydrocannabinols… »; annex IV, « benzo[c]chromene » clause) (new tab)
- ANSM, decision of 6 February 2026 amending the list of substances classified as narcotics and the list of psychotropic substances (new tab)
- PubChem, delta4-Tetrahydrocannabinol, 1R-trans-, CID 91936925 (new tab)
History
- Source
- A positional isomer of tetrahydrocannabinol obtained by total synthesis, not isolated from the plant and with no source describing its formation from a plant extract. Its double bond lies between carbons 6a and 7 (dibenzopyran numbering), at the junction of the central ring and the terpenoid ring, hence its other name Δ6a,7-THC; terpenoid numbering calls it Δ4-THC.
Origin
Laboratory synthesis
No plant pathway. The only described preparation (Arnone et al. 1975) belongs to the acid condensation of an olivetol-type phenol with a monoterpenoid precursor, the class of reactions that forms the dibenzopyran skeleton.
Legal framework
- European Union
Internationally, Δ4-THC is in Schedule I of the 1971 Convention on Psychotropic Substances, among the six tetrahydrocannabinol isomers listed "and their stereochemical variants", under the name (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol. The WHO noted in 2018 that these isomers had never been subject to a critical review. The European Union keeps no list of its own: each Member State applies the Convention in its national law.
- France
In France, Δ4-THC is not listed by name. It falls under the generic entry "Tetrahydrocannabinols, their esters, ethers, salts as well as the salts of the aforementioned derivatives" of the narcotics list (decree of 22 February 1990), an entry moved from annex IV to annex III by the ANSM decision of 6 February 2026; its structure also meets the generic "benzo[c]chromene" clause of annex IV (decisions of 22 May and 3 June 2024). Production, possession, supply and use are prohibited.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Synthetic CB receptor agonist › Research ligand or medicine
- Chemistry
C5 side chain · neutral form
- Class
classical
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
Δ4-Tetrahydrocannabinol (new tab)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- WHO, Expert Committee on Drug Dependence. Isomers of THC: Critical Review Report, 41st meeting, 2018 (new tab)
- Arnone A, Merlini L, Servi S. Hashish: synthesis of (+)-Δ4-tetrahydrocannabinol. Tetrahedron 1975;31:3093-3096 (new tab)DOI 10.1016/0040-4020(75)80154-2
- ANSM, consolidated list of substances classified as narcotics, updated 16 February 2026 (annex III, « Tetrahydrocannabinols… »; annex IV, « benzo[c]chromene » clause) (new tab)
- ANSM, decision of 6 February 2026 amending the list of substances classified as narcotics and the list of psychotropic substances (new tab)
- PubChem, delta4-Tetrahydrocannabinol, 1R-trans-, CID 91936925 (new tab)
Identifiers
Names
- Common name
- Δ4-tetrahydrocannabinol (Δ6a,7-THC)
- IUPAC name
- (9R,10aR)-6,6,9-trimethyl-3-pentyl-8,9,10,10a-tetrahydrobenzo[c]chromen-1-ol
- Other names
- Δ6a,7-THC · delta-6a(7)-THC · delta-4-THC
Identifiers
- Formula
- C₂₁H₃₀O₂
- CAS
- 59042-44-3
- PubChem CID
- 91936925(new tab)
- InChIKey
- UQOUHXDCXBITSF-GDBMZVCRSA-N
- SMILES
- CCCCCC1=
CC2= C([C@@H] 3C[C@@H] (CC= C3C(O2) (C) C) C) C(= C1) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.